4//SEC Filing
Agger Mette Kirstine 4
Accession 0001209191-24-002929
CIK 0001907108other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:57 PM ET
Size
5.6 KB
Accession
0001209191-24-002929
Insider Transaction Report
Form 4
Agger Mette Kirstine
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-02+36,000→ 36,000 totalExercise: $17.00Exp: 2034-02-01→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option shall vest and become exercisable on November 2, 2024, and 1/48th of the shares underlying the option shall vest in equal monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001722234
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:57 PM ET
- Size
- 5.6 KB